Objectives: To describe the incidence, prevalence, characteristics, and management of shoulder injuries requiring medical attention in elite female cricket players. Design: Retrospective cohort. Setting: Australian state, territory, and national cricket teams between July 2015 and June 2023. Participants: Elite female cricket players. Independent variables: Medical attention and general time-loss shoulder injuries. Main outcome measures: Incidence, prevalence, characteristics, recovery time-frames, activity modifications. Results: 409 shoulder injuries were recorded, with an average incidence of 12.9 per 100 players per season. Gradual onset injuries were most commonly experienced by pace bowlers (51%). Sudden onset injuries were most commonly sustained whilst fielding (69%). Four in five injuries did not require the player to be unavailable to play or train. Modified activities (e.g., throwing, diving, bowling) were typically required for between 2 weeks and 6 months. Players typically returned to full unrestricted match play between 1-8.5 months, longer for recurrent injuries (p=0.007). Conclusions: Shoulder injuries are a considerable burden in elite female cricket players. Despite only one in five injuries resulting in a player being unavailable to play or train, impaired shoulder function may reduce the overall performance of the player and the team. Risk reduction strategies may be targeted to at risk players (pace bowlers) and activities (throwing and diving) to reduce the burden of shoulder injuries in this cohort. Further consideration may also be given to management strategies to reduce the risk of exacerbations and recurrent injuries which may prolong recovery.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Human Ethics Committee of La Trobe University gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Non-identifiable data are available upon reasonable request